AS
Therapeutic Areas
ADvantage Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AD04™ | Early Alzheimer's Disease | Phase 2 |
Leadership Team at ADvantage Therapeutics
FM
Frank Mattner
Co-Founder, Research Lead
WS
Walter Schmidt
Co-Founder
JM
Jeffrey Madden
Co-Founder
AF
Agustin Fernandez
Co-Founder